Stephen V. Liu

Also affiliated with Georgetown University Medical Center, Vince Lombardi Cancer Clinic, Georgetown Lombardi Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.688Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America

Annals of Hepatology(2020)10.1016/j.aohep.2020.01.005

Top 34%

0.579DataRank

Top 34%9 citations

Stephen V. Liu, Abdus S. Wahed, Colina Yim, Bettina E. Hansen, Mandana Khalili +7 more

Papers

Driven by 21 papers — median percentile 47. Top paper: “Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study”.

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00247-3

N/A

5.0DataRank · unranked

445 citations

Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik +20 more

Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America

Annals of Hepatology(2020)10.1016/j.aohep.2020.01.005

Top 34%

0.579DataRank

Top 34%9 citations

Stephen V. Liu, Abdus S. Wahed, Colina Yim, Bettina E. Hansen, Mandana Khalili +7 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

A phase II study of atezolizumab and cobimetinib in PD-1/PD-L1 inhibitor resistant or refractory non-small cell lung cancer: ETCTN #10166.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9638

N/A

0DataRank · unranked

1 citations

Richard D. Hall, Andreas Saltos, Gregory A. Otterson, Ming Tan, Sacha Gnjatic +5 more

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology(2021)10.1038/s41571-021-00487-z

N/A

0DataRank · unranked

140 citations

Justin F. Gainor, Aparna Hegde, Alison M. Schram, Giuseppe Curigliano, Sumanta K. Pal +19 more

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.010

N/A

0DataRank · unranked

42 citations

Zofia Piotrowska, Kevin Stirling, Stephen V. Liu, Mandeep K. Banwait, Kristen Cunanan +5 more

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung Cancer(2021)10.1016/j.lungcan.2021.08.010

N/A

0DataRank · unranked

15 citations

Mohammad Asad, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Ammar Sukari, Yasmine Baca +18 more

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e21000

N/A

0DataRank · unranked

0 citations

Yasmine Baca, Joanne Xiu, Rong‐Fu Wang, J. Nicholas Bodor, Chul Kim +8 more

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Annals of Oncology(2022)10.1016/j.annonc.2022.08.002

N/A

0DataRank · unranked

181 citations

Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more

Prioritizing Measures That Matter Within a Person-Centered Oncology Learning Health System

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac037

N/A

0DataRank · unranked

6 citations

Alice Kennedy, Kathryn B Kirkland, Konstantin H. Dragnev, Steven D. Leach, Madge E. Buus‐Frank +81 more

Molecular characterization of nectin-4 in non-small cell lung cancer subtypes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21119

N/A

0DataRank · unranked

2 citations

Nishant Gandhi, Chul Kim, Hirva Mamdani, Balázs Halmos, Ari M. Vanderwalde +5 more

Suspected Nonfatal Cocaine-Involved Overdoses Overall and With Co-involvement of Opioids

Journal of Public Health Management and Practice(2023)10.1097/phh.0000000000001719

N/A

0DataRank · unranked

0 citations

Stephen V. Liu, Cassandra M. Pickens, Lawrence Scholl

Supplementary Figure S3 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.22478576

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Data from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.c.6529985

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Data from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

(2023)10.1158/1078-0432.c.6529985.v1

N/A

0DataRank · unranked

0 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1552

N/A

0DataRank · unranked

12 citations

Shane A. Olwill, Erika Hamilton, Anthony W. Tolcher, Paula R. Pohlmann, Stephen V. Liu +16 more

Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.19.613876

N/A

0DataRank · unranked

5 citations

Katherine H. Shutta, Chen Chen, Viola Fanfani, Enakshi Saha, Panagiotis Mandros +10 more

Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3555

N/A

0DataRank · unranked

81 citations

Anh T. Le, Andrea E. Doak, Vijaya G. Tirunagaru, Shevan Silva, Matthew R. Bull +6 more

Characteristics, treatment patterns, and outcomes of HIV-associated lung cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.8050

N/A

0DataRank · unranked

0 citations

Ujjwal Karki, Tianzhi Tang, Anya Gupta, Kanchi Krishnamurthy, Camelia Bencheqroun +13 more

Development and Validation of a Syndrome Definition to Identify Suspected Nonfatal Heroin-Involved Overdoses Treated in Emergency Departments

Journal of Public Health Management and Practice(2020)10.1097/phh.0000000000001271

N/A

0DataRank · unranked

9 citations

Stephen V. Liu, Alana M. Vivolo‐Kantor, Amy Board, Zachary Stein, Douglas R. Roehler +5 more

540P Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.08.654

N/A

0DataRank · unranked

1 citations

Filippo de Braud, Alexander Drilon, Robert C. Doebele, Manish R. Patel, Byoung Chul Cho +15 more

Stephen V. Liu

Indexed papers

Top data-sharing exemplar

Papers